Aspirin in Obese T2D with Atherogenic Dyslipidemia: Identifying the Ideal Candidates Dr. Srinivas Kudva12 Nov 2025 12:00 PM ISTIndia faces a rapidly escalating triple syndemic of obesity, type 2 diabetes (T2D), and atherogenic dyslipidemia, conditions that frequently overlap...
Risk Beyond Control: Inherited and Causal CV Risk Factors and the Role of Aspirin Dr. Prakash Kumar11 Nov 2025 11:30 AM ISTCardiovascular diseases (CVDs) are the leading cause of non-communicable disease (NCD) deaths in India, accounting for nearly 48% of all NCD...
Long-Acting Relief in Allergic Rhinitis: A Clinical Update on Dual Molecule Approach Dr. Kamal Kant Kohli10 Nov 2025 10:58 AM ISTAllergic rhinitis (AR) is a pervasive health burden affecting over 400 million individuals globally, presenting with a wide range of nasal symptoms...
H2 receptor antagonists (H2RAs) in Gastrointestinal Care of Neonates and Infants: Indian Paediatricians' Perspectives Dr. Garima Soni8 Nov 2025 11:50 AM ISTGastrointestinal (GI) conditions are common in neonates and infants. These may include Gastroesophageal Reflux (GER), Gastroesophageal Reflux...
A Hidden Epidemic: Addressing Visceral Fat and Insulin Resistance in Non-Obese T2DM with Pioglitazone-Based Therapies Dr. K M Suryanarayana VSM5 Nov 2025 11:15 AM ISTMetabolically unhealthy non-obese individuals (MUNO) comprise around 20% of the normal-weight population and have a 3.14-fold higher risk of...
Prediabetes and Cancer Risk: The Overlooked Connection Dr. Khushboo Agarwal3 Nov 2025 11:10 AM ISTPrediabetes burden is rising globally and in India. The latest IDF 2025 Atlas estimated that in 2024, 634.8 million adults (12%) worldwide had IGT,...
Dapagliflozin and Sitagliptin FDC: Exploring Early Initiation Benefits In Young Newly Diagnosed T2D in India Dr. Rajiv Kovil1 Nov 2025 10:34 AM ISTType 2 diabetes (T2D) is a growing epidemic in India. India has 101 million people with diabetes and 136 million with prediabetes, with disease onset...
Advancements in Antifungal Treatment: Insights from In vitro Trials with Selenium Sulfide Dr. Kamal Kant Kohli30 Oct 2025 11:15 AM ISTFungal infections represent a significant challenge in human medicine. With increasing resistance to conventional antifungal therapies and the...
India's Unique CV Risk Profile: How to Decode the Role of Aspirin? Dr. Ajay U. Mahajan7 Oct 2025 11:47 AM ISTCardiovascular disease remains one of the dominant non-communicable causes of death in India, contributing substantially to premature morbidity and...
Identifying Aspirin Candidates for Primary Prevention: Focus on Men Aged 40- 50 with Metabolic Syndrome and Cardiometabolic Risk Lalhmangaihkimi29 Sept 2025 12:15 PM ISTUnique CV Risk in India- Epidemiological BackdropCardiovascular diseases (CVDs) remain the leading cause of death in India, with a WHO-reported...
Undenatured Collagen in Osteoarthritis Management: Practitioner's Review in 2025 Naresh Pincha22 Sept 2025 11:18 AM ISTOsteoarthritis is the most prevalent musculoskeletal disorder globally and the leading cause of chronic pain and disability. In India, over 62 million...
Exploring Buccal Prochlorperazine: A Targeted Review of Its Pharmacological Profile Dr. Kamal Kant Kohli9 Sept 2025 12:15 PM ISTThe Clinical Value of Buccal ProchlorperazineProchlorperazine remains a clinically valuable agent for managing nausea, dizziness, vertigo, and...
